BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1375800)

  • 1. Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production.
    Tremollieres FA; Strong DD; Baylink DJ; Mohan S
    Acta Endocrinol (Copenh); 1992 Apr; 126(4):329-37. PubMed ID: 1375800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.
    Mohan S; Baylink DJ
    Growth Regul; 1991 Sep; 1(3):110-8. PubMed ID: 1726835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells.
    Mohan S; Strong DD; Lempert UG; Tremollieres F; Wergedal JE; Baylink DJ
    Acta Endocrinol (Copenh); 1992 Dec; 127(6):555-64. PubMed ID: 1283479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
    Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.
    Knutsen R; Honda Y; Strong DD; Sampath TK; Baylink DJ; Mohan S
    Endocrinology; 1995 Mar; 136(3):857-65. PubMed ID: 7532581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of mitogenic action of aluminum ion on human bone cells: potential involvement of the insulin-like growth factor regulatory system.
    Lau KH; Utrapiromsuk S; Yoo A; Mohan S; Strong DD; Baylink DJ
    Arch Biochem Biophys; 1993 Jun; 303(2):267-73. PubMed ID: 7685579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells.
    Owens PC; Gill PG; De Young NJ; Weger MA; Knowles SE; Moyse KJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):467-73. PubMed ID: 7685593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
    Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
    J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
    Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
    J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.
    Kanzaki S; Hilliker S; Baylink DJ; Mohan S
    Endocrinology; 1994 Jan; 134(1):383-92. PubMed ID: 7506211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells.
    Durham SK; Riggs BL; Harris SA; Conover CA
    Endocrinology; 1995 Apr; 136(4):1374-80. PubMed ID: 7534697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system.
    Lau KH; Goodwin C; Arias M; Mohan S; Baylink DJ
    Bone; 2002 May; 30(5):705-11. PubMed ID: 11996908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
    Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
    Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells.
    Conover CA; Kiefer MC
    J Clin Endocrinol Metab; 1993 May; 76(5):1153-9. PubMed ID: 7684391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1.
    Hurley MM; Abreu C; Hakeda Y
    J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
    Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
    Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C; Silve C; Rosato R; Segovia B; Binoux M
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.